Potential CB Product Sponsored Post:
These other companies might also be well exposed to the psychedelic medicine market, which Eight Capital claims could be worth around $100 billion.
This might get you interested! Check this out! It was said that US FDA appears to be supportive of psilocybin research. In 2018, for example, the agency recognized psilocybin as a potential “breakthrough therapy” for depression.
These other companies clinical studies from prestigious institutions such as Johns Hopkins Medicine, and New York University appear to already be showing positive results. Check disclaimer on landing page and in my profile.